Immunitybio Inc (IBRX)

SG&A Expense Growth

13.87%

Quarterly · Period ending:

IBRX logo

IBRX SG&A Expense Growth

Latest reported13.87%
IBRX Quarterly SG&A Growth (QoQ) (0.00% → 13.87%)
High-resolution chart · PNG

IBRX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
13.8661%
17.5191%
15.2356%
-22.455%
29.6564%
-21.7512%
16.1906%
-27.0756%
17.5862%
26.5026%
4.0671%
-0.6309%
19.0349%
9.5062%
37.7236%
18.2065%
-61.5984%
40.7689%
-5.7857%
-8.6916%
-28.3379%
438.7316%
-57.1137%
6.8077%
93.2687%
11.3418%
111.8261%
-3.7542%
-27.1682%
9.4548%
-45.2401%
-29.5277%
-4.9238%
6.8211%
0.0299%
-5.2874%
-12.9352%
3.2712%
-35.6631%
-14.569%
7.268%
-64.3851%
92.5954%
-52.8637%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.